Evonik Evonik

X

Find Firibastat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Firibastat
Also known as: Qgc-001, 648927-86-0, Rb-150, Qgc001, Rb150, 638ky4573i
Molecular Formula
C8H20N2O6S4
Molecular Weight
368.5  g/mol
InChI Key
HJPXZXVKLGEMGP-YUMQZZPRSA-N
FDA UNII
638KY4573I

QGC001 has been used in trials studying the treatment of Essential Hypertension.
1 2D Structure

Firibastat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3S)-3-amino-4-[[(2S)-2-amino-4-sulfobutyl]disulfanyl]butane-1-sulfonic acid
2.1.2 InChI
InChI=1S/C8H20N2O6S4/c9-7(1-3-19(11,12)13)5-17-18-6-8(10)2-4-20(14,15)16/h7-8H,1-6,9-10H2,(H,11,12,13)(H,14,15,16)/t7-,8-/m0/s1
2.1.3 InChI Key
HJPXZXVKLGEMGP-YUMQZZPRSA-N
2.1.4 Canonical SMILES
C(CS(=O)(=O)O)C(CSSCC(CCS(=O)(=O)O)N)N
2.1.5 Isomeric SMILES
C(CS(=O)(=O)O)[C@@H](CSSC[C@H](CCS(=O)(=O)O)N)N
2.2 Other Identifiers
2.2.1 UNII
638KY4573I
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4,4'-dithio(bis(3-aminobutyl Sulfonic Acid))

2. Rb 150

3. Rb-150

4. Rb150

5. Rb150 Cpd

2.3.2 Depositor-Supplied Synonyms

1. Qgc-001

2. 648927-86-0

3. Rb-150

4. Qgc001

5. Rb150

6. 638ky4573i

7. 1-butanesulfonic Acid, 4,4'-dithiobis(3-amino-, (3s,3's)-

8. (s)-3-amino-4-(((s)-2-amino-4-sulfobutyl)disulfaneyl)butane-1-sulfonic Acid

9. Unii-638ky4573i

10. Qgc 001

11. Firibastat [inn]

12. Firibastat [who-dd]

13. Schembl1694944

14. Chembl4297511

15. (3s,3's)-4,4'-dithiobis(3-aminobutane-1-sulfonic Acid)

16. Glxc-25368

17. Db13107

18. Hy-109058

19. Cs-0032985

20. 4,4'-dithio(bis(3-aminobutyl Sulfonic Acid))

21. Q27263587

22. (3s,3's)-4,4'-disulfanediylbis(3-aminobutane-1-sulfonicacid)

23. (3s,3s')-4,4'-disulfanediylbis(3-aminobutane-1-sulfonic Acid)

24. (3s)-3-amino-4-[[(2s)-2-amino-4-sulfobutyl]disulfanyl]butane-1-sulfonic Acid

25. 1601301-49-8

2.4 Create Date
2008-07-14
3 Chemical and Physical Properties
Molecular Weight 368.5 g/mol
Molecular Formula C8H20N2O6S4
XLogP3-6.9
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count10
Rotatable Bond Count11
Exact Mass368.02042106 g/mol
Monoisotopic Mass368.02042106 g/mol
Topological Polar Surface Area228 Ų
Heavy Atom Count20
Formal Charge0
Complexity410
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY